Core Viewpoint - The company, Yidu Tech (02158), is actively engaging in share buybacks and has recently announced significant partnerships and achievements in the healthcare data industry [1] Share Buyback Activity - On January 27, Yidu Tech repurchased approximately 378,600 shares at a price of around HKD 6 per share, totaling nearly HKD 2.3 million [1] - The company has conducted buybacks for two consecutive days, accumulating a total of 505,000 shares repurchased and over HKD 3 million in total buyback amount [1] Industry Engagement and Partnerships - Yidu Tech's founder and chairman, Gong Rujing, participated in the 2026 Winter Davos Forum, engaging in high-level industry dialogues and meetings with global leaders [1] - At the forum, a significant collaboration was announced involving the Novartis Foundation, the Brunei Ministry of Health, and Yidu Tech's subsidiary, EVYD, to implement a smart-driven cardiovascular disease prevention project called CARDIO4Cities [1] Industry Recognition - Yidu Tech has been recognized as the top company in the "2025 Medical Big Data Company Rankings," marking its seventh consecutive year at the top, reflecting its strong technological foundation, mature product system, and extensive industry experience [1]